Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

Credit Suisse 31st Annual Healthcare Conference A virtual presentation will be made live starting on Tuesday, November 8, 2022

Stifel 2022 Healthcare ConferenceFireside chat: Wednesday, November 16, 2022 at 10:20 am ESTLocation: Lotte New York Palace Hotel, New York, NY

Jefferies London Healthcare ConferenceFireside chat: Thursday, November 17, 2022 at 3:15 pm GMT (10:15 am EST)Location: The Waldorf Hilton, London, UK

A live webcast and archived replay of the fireside chats along with a replay of the pre-recorded presentation will be available on the investors section of www.vorbio.com.

About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & InvestorsSarah Spencer +1 857-242-6076[email protected]

You May Also Be Interested In

• Ministry of Information & Broadcasting, Pakistan: The Morning After - An Independence Day Message
• Ministry of Information & Broadcasting, Pakistan: The Morning After - An Independence Day Message
• Summit Growth Group Announces Launch to Help Broadband Providers Accelerate Customer Acquisition